• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者的无症状泌尿系统异常、血尿和蛋白尿。初步研究。

Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.

作者信息

Velciov Silvia, Gluhovschi Gh, Sporea I, Trandafirescu Virginia, Petrica Ligia, Bozdog Gh, Gluhovschi Cristina, Bob F, Gădălean Florica, Buzaş Roxana, Bobu Maria, Voicu L

机构信息

Nephrology Department, University of Medicine and Pharmacy Timişoara, Romania.

出版信息

Rom J Intern Med. 2011;49(2):113-20.

PMID:22303602
Abstract

The study assesses the presence of asymptomatic urinary anomalies in patients with inflammatory bowel disease. Asymptomatic urinary anomalies are mainly due to glomerular nephritis, they being one of the forms of its manifestation, together with chronic nephrotic and nephritic syndromes. We identified urinary anomalies in 18 patients (20%) with bowel inflammatory disease that consisted of haematuria in 8 (9%) patients, isolated proteinuria in 5 (6%) patients and haematuria associated with proteinuria in 5 (6%) patients. Asymptomatic urinary anomalies were more frequent in patients with the Crohn disease than in those with ulcerative colitis. We identified RFG under 60ml/min in 4 patients with asymptomatic urinary anomalies. It is very easy to evaluate asymptomatic urinary anomalies with dipstick. This method is also required in current practice for patients with urinary anomalies for identifying the glomerular disease that might have caused them. One must take into consideration differential diagnosis with other diseases that can manifest themselves with proteinuria or isolated proteinuria. One must also take into account the fact that urinary anomalies may also be related to administration of 5-aminosalicylates.

摘要

该研究评估了炎症性肠病患者中无症状性泌尿系统异常的存在情况。无症状性泌尿系统异常主要归因于肾小球肾炎,它是肾小球肾炎的表现形式之一,与慢性肾病综合征和肾炎综合征并存。我们在18例(20%)肠道炎症性疾病患者中发现了泌尿系统异常,其中8例(9%)患者出现血尿,5例(6%)患者出现单纯蛋白尿,5例(6%)患者出现血尿合并蛋白尿。无症状性泌尿系统异常在克罗恩病患者中比在溃疡性结肠炎患者中更常见。我们在4例有无症状性泌尿系统异常的患者中发现肾小球滤过率低于60ml/分钟。使用试纸条评估无症状性泌尿系统异常非常容易。目前在临床上,对于有泌尿系统异常的患者,也需要这种方法来识别可能导致这些异常的肾小球疾病。必须考虑与其他可表现为蛋白尿或单纯蛋白尿的疾病进行鉴别诊断。还必须考虑到泌尿系统异常也可能与5-氨基水杨酸酯的使用有关。

相似文献

1
Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.炎症性肠病患者的无症状泌尿系统异常、血尿和蛋白尿。初步研究。
Rom J Intern Med. 2011;49(2):113-20.
2
Pulmonary complications in patients with inflammatory bowel disease.炎症性肠病患者的肺部并发症
Hepatogastroenterology. 1999 May-Jun;46(27):1714-9.
3
Elements of renal injury in patients with erysipelas.丹毒患者肾损伤的相关因素。
Rom J Intern Med. 2010;48(2):179-85.
4
[Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].[溃疡性结肠炎患者蛋白尿的特征及氨基水杨酸盐治疗]
Med Klin (Munich). 2006 Oct 15;101(10):791-5. doi: 10.1007/s00063-006-1106-9.
5
Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.炎症性肠病患者中柳氮磺胺吡啶诱发的银屑病
Eur J Dermatol. 2011 Sep-Oct;21(5):784-5. doi: 10.1684/ejd.2011.1438.
6
[Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].[炎症性肠病中的肾小管间质性肾炎:肠外表现还是药物毒性?]
Ned Tijdschr Geneeskd. 2010;154:A1647.
7
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.炎症性肠病中的轻度肾功能不全与疾病活动有关,但与使用5-氨基水杨酸无关。
Aliment Pharmacol Ther. 2001 Mar;15(3):363-9. doi: 10.1046/j.1365-2036.2001.00940.x.
8
[Chronic inflammatory bowel diseases. Update on evidence-based therapy].[慢性炎症性肠病。循证治疗的最新进展]
MMW Fortschr Med. 2005 Apr 28;147(17):58-9.
9
Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.对于静止期溃疡性结肠炎患者,美沙拉嗪每日一次给药比每日两次给药更有效。
Clin Gastroenterol Hepatol. 2009 Jul;7(7):762-9. doi: 10.1016/j.cgh.2009.04.004. Epub 2009 Apr 16.
10
Accidentally ASCENDing into comparative effective research for inflammatory bowel disease.意外涉足炎症性肠病的比较有效性研究领域。
Gastroenterology. 2009 Dec;137(6):1880-2. doi: 10.1053/j.gastro.2009.10.014. Epub 2009 Oct 29.

引用本文的文献

1
Renal manifestations in inflammatory bowel disease: a systematic review.炎症性肠病的肾脏表现:系统评价。
J Gastroenterol. 2022 Sep;57(9):619-629. doi: 10.1007/s00535-022-01903-6. Epub 2022 Jul 14.
2
Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia.沙特阿拉伯炎症性肠病患者肾结石的患病率
Cureus. 2021 Jun 21;13(6):e15787. doi: 10.7759/cureus.15787. eCollection 2021 Jun.
3
Renal involvement in paediatric inflammatory bowel disease.儿科炎症性肠病的肾脏受累。
Pediatr Nephrol. 2021 Feb;36(2):279-285. doi: 10.1007/s00467-019-04413-5. Epub 2019 Dec 9.
4
Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.炎症性肠病患者终末期肾病风险增加:一项全国范围内基于人群的研究。
World J Gastroenterol. 2018 Nov 14;24(42):4798-4808. doi: 10.3748/wjg.v24.i42.4798.